Lista de obras -

An insight of novel pharmacological therapies in hypertrophic cardiomyopathy.

artículo científico publicado en 2011

Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis

artículo científico publicado en 2009

Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test

artículo científico publicado en 2018

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.

artículo científico publicado en 2010

CALU polymorphism A29809G affects calumenin availability involving vascular calcification

artículo científico publicado en 2015

Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy.

artículo científico publicado en 2015

Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy

artículo científico publicado en 2011

Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation

artículo científico publicado en 2012

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

artículo científico publicado en 2017

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

artículo científico publicado en 2014

Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

artículo científico publicado en 2019

Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.

scientific article published on 12 January 2017

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

artículo científico publicado en 2010

Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy

artículo científico publicado en 2011

High-sensitivity troponin T and copeptin in non-ST acute coronary syndromes: implications for prognosis and role of hsTnT and copeptin in non-STEACS.

artículo científico publicado en 2012

High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery.

artículo científico publicado en 2013

Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches

artículo científico publicado en 2013

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy

artículo científico publicado en 2011

Implications of pharmacogenetics for oral anticoagulants metabolism.

artículo científico publicado en 2009

Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study

artículo científico publicado en 2011

Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification

artículo científico publicado en 2018

Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2012

Lone atrial fibrillation - a diagnosis of exclusion

artículo científico

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion.

artículo científico publicado en 2016

New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

artículo científico publicado en 2016

Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

scientific article published on 13 February 2010

Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.

artículo científico publicado en 2011

Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold.

artículo científico publicado en 2016

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

artículo científico publicado en 2012

Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy

artículo científico publicado en 2010

Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.

artículo científico publicado en 2013

Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin

artículo científico publicado en 2014

Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

artículo científico publicado en 2010

TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy

artículo científico publicado en 2015

The prognostic role of the adiponectin levels in atrial fibrillation

artículo científico publicado en 2012

The prognostic value of biomarkers after a premature myocardial infarction

artículo científico publicado en 2009

Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery

scientific article published on 12 November 2015

Lista de obras de

An insight of novel pharmacological therapies in hypertrophic cardiomyopathy.

Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis

Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.

CALU polymorphism A29809G affects calumenin availability involving vascular calcification

Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy.

Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy

Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy

High-sensitivity troponin T and copeptin in non-ST acute coronary syndromes: implications for prognosis and role of hsTnT and copeptin in non-STEACS.

High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery.

Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy

Implications of pharmacogenetics for oral anticoagulants metabolism.

Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study

Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification

Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes

Lone atrial fibrillation - a diagnosis of exclusion

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion.

New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.

Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold.

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy

Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.

Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin

Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy

The prognostic role of the adiponectin levels in atrial fibrillation

The prognostic value of biomarkers after a premature myocardial infarction

Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery